Pfizer Revises Zoloft Ad After FDA Cites Lack Of Suicide Information
Executive Summary
Pfizer is revising Zoloft (sertraline) advertisements after FDA cited the company for not incorporating updated risk information in a print ad for the antidepressant
You may also be interested in...
FDA Ad Warning Letters On Track For Significant Increase In 2005
FDA is on track for a significant increase in the number of warning letters issued to drug marketers for advertising violations in 2005
FDA Ad Warning Letters On Track For Significant Increase In 2005
FDA is on track for a significant increase in the number of warning letters issued to drug marketers for advertising violations in 2005
FDA Challenges Four Rx Ads; TAP Decides To Suspend Prevacid TV Campaign
TAP's decision to suspend Prevacid TV commercials could be an early indication of a decline in broadcast advertising for pharmaceutical products